The aim of this study was to ascertain the prevalence of erectile dysfunction (ED), how it is perceived and the percentage seeking treatment for the condition in a population of men with cardiovascular disease (CVD) attending a cardiac rehabilitation programme in East London, UK. One hundred male subjects aged between 30 and 88 years attending a cardiac rehabilitation centre in East London participated in the study. An audit of men attending a cardiac rehabilitation programme was conducted. Participants completed the International Index of Erectile Function (IIEF-5) to ascertain the severity of ED, an adapted 'bother score' item from the International Prostate Symptom Score (IPSS) to investigate the extent to which participants were bothered by the symptoms of their ED and questions related to both ED treatment-seeking and beliefs about the impact of cardiac medication on ED. Demographic and clinical data were also collected. The audit was carried out between January and September 2014. Out of 117 male participants, 100 were audited (85·5% uptake). Prevalence of ED in this cohort was 80%, and 38% were suffering with moderate or severe ED. Older men had significantly higher levels of ED, and participants with severe ED were significantly more bothered by their condition. Those of Asian or British Asian descent reported significantly higher levels of ED severity than men from white ethnic backgrounds. Sixty-five percent of men with ED had never spoken to a health care professional (HCP) about the condition, and 35% believed that their medication had a deleterious effect on erectile function. High incidences of ED remain undetected in this patient population. The study stresses the importance for HCPs to discuss ED with patients within primary care and cardiac rehabilitation programmes, which in turn could reduce mortality in those at risk of a future cardiac event as well as facilitate access to ED treatment.
INTRODUCTION
The term cardiovascular disease (CVD) refers to all diseases of the heart and circulatory system and costs the NHS and the UK economy approximately £30·6 billion per year (Care Quality Commission, 2009) Coronary heart disease (CHD) is one such disease and is the biggest single cause of death in the UK. For men, CHD is the most common cause of premature death (mortality before 75 years of age) and was responsible for over 15% (>17 000) of premature deaths in 2012 (Bhatnagar et al., 2015) .
Erectile dysfunction (ED) is defined as a man's consistent or recurrent inability to attain and/or maintain a penile erection sufficient for sexual activity (Montorsi et al., 2010) . Prevalence rates of ED for individuals at risk of, or suffering with, CVD are reported to be as high as 75% (Dusing, 2003; British Heart Foundation, 2014) . ED and CVD share similar aetiologies and risk factors, including obesity, diabetes mellitus, physical inactivity, hypertension, dyslipidaemia and tobacco usage (Ponholzer et al., 2005) . ED is typically experienced before the onset of a cardiac event and can be regarded as an early indication of underlying CVD (Montorsi et al., 2003) . Due to arteries in the penis being approximately 1-2 mm compared to larger arteries, such as coronary arteries (3-4 mm), they suffer obstruction by atheromatous plaque sooner (Jackson, 2013) . Therefore, early diagnosis of ED can be a crucial indication of undetected CVD. The mean time between developing ED and having a cardiovascular event, such as myocardial infarction or cerebrovascular accident, is approximately 3 years (Montorsi et al., 2003) .
Medication prescribed for CVD can cause further deleterious effects in relation to erectile function (Nicolai et al., 2014) . Side effects of antihypertensive medications (particularly -blockers and thiazide diuretics) can cause ED (Dusing, 2005) . As a result, patients who experience ED as a side effect can become non-adherent to such medication regimes (Doumas and Douma, 2006) . In a qualitative study involving a cohort of 38 hypertensive patients, ED was reported as a reason for missing doses or for ceasing hypertensive medication to preserve erectile function; however, the authors do not report which hypertensive medications patients were taking (Voils et al., 2008) . A recent systematic review provides support for the notion that both thiazide diuretics and a majority of -blockers have a negative effect on erectile function, whilst the -blocker Nebivolol may have a positive effect. It is suggested that this is due to nitric oxide-mediated vasodilatory properties, which improve endothelial function and hence erectile function. In addition, it was concluded that there was no evidence to suggest that angiotensin-converting enzyme (ACE) inhibitors, angiotensin-receptor blockers (ARBs) and calcium-channel blockers have a deleterious effect on erectile function (Baumhakel et al., 2011) .
In addition to pharmacological-induced ED, patient perceptions are important when considering the effects of CVD medication on ED. Ninety-six men prescribed atenolol for CVD were split up into three groups: one group were blinded to the drug given, the second were informed about the drug but not its side effects, and the final group were informed about the drug and its side effects, which included ED (Silvestri et al., 2003) . ED was reported in 3·1, 15·6 and 31·2% of the groups, respectively. It was suggested that knowledge and beliefs about the potential side effects of CVD medication may create anxiety, which in turn may have an effect on erectile function (Silvestri et al., 2003) . An alternative explanation could be that an awareness of the link between CVD medication and ED may increase the reporting of erectile symptoms.
The International Prostate Symptom Score questionnaire (IPSS) includes an item that is referred to as the 'bother score'. This item has previously been adapted and used in ED research (Steggall and Butler, 2012) . Steggall and Butler (2012) indicated that regardless of ED severity, men who took part in their study were 'bothered' by their condition and perceived their symptoms negatively. Despite this, seeking help in relation to ED is problematic. Research indicates that less than 25% of men actively seek treatment for ED (Laumann et al., 2009) , and embarrassment is often reported as a major reason for not wanting to discuss sexual health issues with a health care professional (HCP) (Byrne et al., 2013) . Hackett recommends that in order to improve detection, patients presenting in primary care with diabetes, obesity, depression or CVD should be asked whether they are experiencing ED (Hackett, 2009) .
This article details an audit of a cardiac rehabilitation service in East London to ascertain the prevalence of ED and whether it has been detected and/or treated. The audit aimed to:
• Investigate the prevalence and severity of ED in a cohort of men attending a community-based cardiac rehabilitation service in East London using the International Index for Erectile Function 
METHODS Participants
All men attending the cardiac rehabilitation programme were eligible for inclusion in the audit.
Procedure
Permission to conduct the audit was obtained from the Assurance Department of East London NHS Foundation Trust (ELFT) and subsequently took place between January and September 2014. ELFT provides a cardiac rehabilitation programme across a variety of locations, including both community and hospital-based settings in East London. Men who were newly referred to the cardiac rehabilitation programme were given the audit questionnaire to complete when they arrived to participate in one of the cardiac rehabilitation sessions. Participants were informed that all questionnaire responses would be anonymous. In accordance with the Data Protection Act 1998 (Parliament, 1998), all aspects of participants' data were treated with strict confidence. Each participant was assigned a unique identification number to ensure that data were anonymized. Hard copies of questionnaires were stored within locked filing cabinets in a locked office on NHS premises along with digital data, which were stored on an NHS password-protected network drive.
Materials
As part of standard care, participants completed a self-report questionnaire. Clinical and demographic data were extracted from participants' medical records.
Where participants could not speak English, a member of the Trusts health advocacy service translated the questions and recorded participants' responses. The pack included the IIEF-5, a self-report questionnaire designed to detect the presence and severity of ED (Rosen et al., 1999) . It has been utilized successfully across a wide variety of studies, translated into more than 30 languages and used extensively throughout the world (Cappelleri and Rosen, 2005) . Each item of the IIEF-5 is scored on a 5-point Likert scale, from '1' least functional to '5' most functional. Possible overall scores range from 1 to 25; 21 and above is considered to indicate normal erectile function. Conversely, lower overall scores represent poorer sexual function (Table  A1 ) (Rhoden et al., 2002) . The 'bother' question from the IPSS was re-worded for use with ED, 'If you were to spend the rest of your life with your erectile function just the way it is now, how would you feel about that?' Using a Likert scale, a score of 0 indicated being 'delighted', 1 'pleased', 2 'mostly satisfied', 3 'mixed', 4 'mostly dissatisfied', 5 'unhappy' and 6 'terrible.' This item has been used in men with ED (Steggall and Butler, 2012) and is considered both valid and reliable (O'Leary, 2005) .
The audit also included the questions 'Do you think any of your medications affect your erectile function?' and 'Have you ever told your doctor or nurse about your erectile problems?' where participants answered either 'Yes' or 'No'.
Statistical analysis
Data were analysed using IBM SPSS Statistics 21. To investigate the prevalence of ED, descriptive statistics were used for participant demographics and clinical data. Analysis of variance (ANOVA) and analysis of covariance (ANCOVA) were used to investigate differences between the five categories of ED severity on age and the subsequent degree of bother as well as differences in ED severity in relation to ethnicity.
RESULTS

Demographic characteristics
Of the 117 men approached, 100 (85·5%) completed the audit. Participants who refused were widowed (n = 2, 1·7%), had a wife who was not living in the country (n = 3, 2·6%) and did not complete the questionnaire or did not wish to participate (n = 12, 10·25%). Ages ranged between 30 and 88 years, with a mean age of 56·82 years (SD = 10·48). A majority of the men were married (77%) and were non-smokers (72%). Patients were mainly Asian or British Asian, that is, Indian, Pakistani or Bangladeshi (n = 49, 49%) (Table A2) .
Clinical characteristics
The majority of participants were attending cardiac rehabilitation as a result of a myocardial infarction (41%) or angina (31%). The most commonly prescribed medications were aspirin (97%) and statins (92%). The most prevalent comorbidities were hypertension (50·5%), hypercholesterolemia (48%) and type 2 diabetes (30%) ( Table A3 ).
ED prevalence, severity and age
Of the 100 men who completed the IIEF-5, 80 (80%) suffered some degree of ED. The self-reported mean duration of ED was 2·8 years (SD = 3·32 years), and the mean IIEF-5 score was 14·91 (SD = 6·5) (Table A4) .
Moderate or severe ED was reported by 38 (38%) men. An ANOVA indicated a significant difference in age between the five categorizations of ED severity; F(4, 95) = 6·59, p = 0·0001, partial eta squared = 0·22. The post hoc Tukey honest significant difference (HSD) test indicated that those with severe ED were significantly older than those with mild to moderate, mild and no ED (Table A5) .
Bother score
Using the IPSS bother question to ascertain how participants felt about spending the rest of their lives with their current erectile function revealed that 11 participants (11%) felt 'delighted', 15 participants (15%) were 'pleased', 1 (1%) was 'mostly satisfied', 26 (26%) had 'mixed' feelings, 18 (18%) felt 'mostly dissatisfied' or 'unhappy' (n = 18, 18%) and 8 men (8%) reported that they felt 'terrible'.
An ANCOVA was used to explore differences between the five categorizations of ED severity and bother whilst controlling for the effects of age (Table  A5) . Results revealed a significant difference between groups on levels of bother, F(4, 91) = 18·59, p < 0·01, partial eta squared = 0·45. Pair-wise comparisons indicated that those with severe ED were significantly more bothered by their symptoms than those with all other ED severities, including those with no ED. Those with mild, mild to moderate and mild ED were significantly more bothered by their symptoms than those with no ED.
Ethnic background was looked at in relation to ED severity (Table A6) . ED severity was treated as a continuous variable as there were too few observations within some cells to perform a 2 test. An ANCOVA was utilized to look for any significant differences between ethnic groups in relation ED whilst controlling for age. A significant difference existed between groups, F(3, 95) = 4·22, p = 0·008, partial eta squared = 0·117. Pair-wise comparisons indicated that Asian or British Asian men scored significantly lower on the IIEF-5 than those from white ethnic backgrounds; therefore, men of Asian or British Asian descent reported significantly higher levels of ED severity than white men.
ED severity and comorbidities
Of the 100 men who took part in the audit, 50 (50%) had hypertension, 30 (30%) had type II diabetes and 19 (19%) had both conditions (Table A7) . Almost all men with diabetes had ED (29/30, 96·7%), and 80% had moderate or severe ED. In men with hypertension, 86% had ED and 46% had moderate to severe ED. All men with both diabetes and hypertension had at least mild ED, and 84% had moderate or severe ED.
Treatment seeking
Of the 80 men with ED, 52 (65%) had never spoken to an HCP about their condition. Of those with moderate or severe ED, 52·6% had spoken to an HCP, while in those with less severe ED, that is, mild or mild to moderate severity, only 14·3% had done so. Of these men, only one individual was receiving treatment for ED. Thirty-five percent of men diagnosed with ED believed that medication was having an effect on their erectile function.
DISCUSSION
The prevalence of ED in this cohort of men attending a cardiac rehabilitation programme was 80%, which is similar to that found in previous research (Dusing, 2003; British Heart Foundation, 2014) . Men with severe ED were significantly older and more bothered by their symptoms. However, even those with mild ED reported feeling either mostly 'dissatisfied' or 'terrible' about their erectile function, echoing the results of Steggall and Butler's (2012) research, which found that men with heart failure, regardless of the severity of their ED, were bothered by the condition. The majority of participants were Asian or British Asian, reflecting the composition of the local community, and these men were experiencing significantly more severe ED than men from white ethnic backgrounds. The scope of this audit was not broad enough to suggest reasons for this; therefore, further research focussing on differences between ethnic groups in relation to ED is needed.
Both ED and CVD share similar aetiologies and risk factors, including diabetes mellitus and hypertension (Ponholzer et al., 2005) . The mean duration of ED in this cohort of men was 2·8 years, echoing the findings of Montorsi et al. (2003) who suggest that the mean time between developing ED and experiencing a cardiovascular event is approximately 3 years. In addition, this audit confirmed that men who were living with comorbid hypertension or type II diabetes were likely to report higher levels of ED severity.
A large proportion of men were prescribed -blockers, which have been reported as having negative effects on erectile function (Baumhakel et al., 2011; Nicolai et al., 2014) . Approximately one third of men believed that their medication impacted their erectile function. It is, however, unclear whether it is the drugs themselves that may be causing this effect or beliefs and expectations men have about possible side effects, as demonstrated by Silvestri et al. (2003) . Future research could address this important question by investigating men's beliefs about their CVD treatment in relation to ED in order to examine whether such beliefs influence men's adherence to cardiac medication.
Despite 80% of the sample suffering with ED, 65% had not discussed their condition with an HCP, reflecting the findings of Laumann et al. (2009) who suggest that less than 25% of men seek help for ED. Byrne et al. (2013) suggest that this is due to embarrassment about discussing sexual health issues with HCPs. A limitation of this audit resides in the potentially embarrassing nature of ED and the format in which participants completed the questionnaire. Cardiac rehabilitation classes are group based. With this in mind, all efforts were made to safeguard participant's privacy when completing the questionnaire; however, it is unlikely that feelings of embarrassment were completely eliminated. This could have been exacerbated in the small number of participants that did not speak English who were read the questions aloud by a health advocate. Although people who do not speak English are likely to have experience of discussing their health with a health advocate, it would be prudent to keep this in mind when considering the results to this audit.
The present audit, in line with previous research, highlights the important link between CVD, diabetes, hypertension and comorbid ED (Ponholzer et al., 2005) . Patients presenting with such diseases offer an opportunity to enquire about and screen for ED. Hackett (2009) suggests that HCPs need to assess ED effectively by asking the right questions and demonstrate a willingness to take ED seriously as a medical condition. The results of this audit suggest that this is still a serious obstacle preventing patients obtaining necessary medical help. It highlights the need for ED to be adequately addressed and screened for in order to detect CVD early and facilitate access to ED treatment. This could be achieved in primary care but is also true of cardiology clinics and cardiac rehabilitation programmes. If the profile of ED can be raised and the topic addressed in various health care settings, then the possibility exists to reduce mortality in those at risk of a future cardiac event as well as increase quality of life in those suffering with ED. 
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